|Bid||219.84 x 1000|
|Ask||220.12 x 800|
|Day's Range||218.98 - 223.60|
|52 Week Range||214.88 - 468.55|
|Beta (5Y Monthly)||0.42|
|PE Ratio (TTM)||21.57|
|Earnings Date||Feb 01, 2022 - Feb 07, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||317.17|
Investment company Oxler Private Wealth LLC (Current Portfolio) buys Ford Motor Co, Verizon Communications Inc, Zoom Video Communications Inc, Shake Shack Inc, Royalty Pharma PLC, sells AT&T Inc, Newmont Corp, Biogen Inc, Barrick Gold Corp, Beyond Meat Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Oxler Private Wealth LLC.
Black and Latino people were underrepresented in the trials on which approval of the Alzheimer's drug was based.
CAMBRIDGE, Mass., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo, Japan) today announced additional details about the Phase 4 post-marketing confirmatory study, ENVISION, of ADUHELM® (aducanumab-avwa) 100 mg/mL injection for intravenous use in early Alzheimer’s disease, including details of the study’s goal for diverse enrollment and primary endpoint. Biogen aims to enroll 18 percent of U.S. participants in ENVISION from Black/African American and Latinx